A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Observation for Patients With Asymptomatic CNS Metastatic Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)
- Status
- COMPLETED
- Phase
- NA
Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care Consultation
- Status
- COMPLETED
- Phase
- N/A
Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- NA
Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
- Status
- UNKNOWN
- Phase
- N/A
RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)
- Status
- TERMINATED
- Phase
- PHASE1
Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer
- Status
- UNKNOWN
- Phase
- N/A
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
- Status
- UNKNOWN
- Phase
- N/A
Stereotactic Radiosurgery (SRS) for Multiple CNS Mets
- Status
- WITHDRAWN
- Phase
- NA
A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1